ctrl K

Price Alert

Ascentage Pharma Group In... (AAPG)

NASDAQ: AAPG · Real-Time Price · USD

46.40

-1.09 (-2.28%)

At close: Aug 19, 2025, 3:58 PM

46.20

-0.42%

After-hours: Aug 19, 2025, 07:21 PM EDT

Ascentage Pharma International Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	980.65M	221.98M	209.71M	4.33M
Cost of Revenue	29.09M	30.54M	22M	3.33M
Gross Profit	951.57M	191.44M	187.71M	24.58M
Operating Income	-369.73M	-872.64M	-849.81M	-869.84M
Interest Income	37.84M	32.41M	9.73M	7.11M
Pretax Income	-395.25M	-932.86M	-887.17M	-832.25M
Net Income	-405.43M	-925.64M	-882.92M	-782.42M
Selling & General & Admin	383.12M	376.46M	328.02M	191.26M
Research & Development	947.25M	706.97M	743.1M	766.49M
Other Expenses	-9.07M	-19.36M	-33.6M	-63.34M
Operating Expenses	1.32B	1.06B	1.04B	894.42M
Interest Expense	64.45M	96.06M	52.78M	16.73M
Selling & Marketing Expenses	196M	195.39M	157.42M	47.75M
Cost & Expenses	1.35B	1.09B	1.06B	897.75M
Income Tax Expense	10.43M	-7.15M	-4.25M	-49.83M
Shares Outstanding (Basic)	75.52M	70.57M	65.92M	63.65M
Shares Outstanding (Diluted)	75.52M	70.57M	65.92M	63.65M
EPS (Basic)	-0.75	-13.12	-13.4	-12.28
EPS (Diluted)	-0.75	-13.12	-13.4	-12.28
EBITDA	-237.63M	-743.61M	-771.47M	-787.19M
EBIT	-330.8M	-836.8M	-834.39M	-815.52M
Depreciation & Amortization	93.17M	93.19M	9.13M	4.39M